Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of June 2026 for Haleon Plc, a consumer health company focused on everyday health across six categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing discloses total voting rights and capital structure as of June 1, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to capital structure and voting rights data.
Material Changes
The filing does not report material changes in financial performance compared to prior periods. It provides a static snapshot of share capital as of May 31, 2026.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, risk factors, contingencies, or discussion of unusual items. It serves solely as a notification of share capital and voting rights.
Capital Structure Details
| Metric | Value |
|---|---|
| Total Ordinary Shares Issued | 8,859,337,794 |
| Share Par Value | £0.01 each |
| Treasury Shares | 12,076,964 |
| Ordinary Shares with Voting Rights | 8,847,260,830 |
Investor Verification Checklist
- Verify the denominator for notification obligations under FCA Disclosure Guidance and Transparency Rules is 8,847,260,830 shares.
- Confirm the total issued share count of 8,859,337,794 as of May 31, 2026.
- Note that this filing does not contain financial performance data; refer to Form 20-F for financial results.